ANGO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
AngioDynamics Inc (ANGO) is not a strong buy at this moment for a beginner investor with a long-term strategy. While the company has shown revenue growth in the latest quarter, the significant drop in net income and EPS, coupled with bearish technical indicators and lack of strong positive catalysts, suggests that the stock does not present an attractive entry point currently.
The MACD is positive and expanding, indicating some bullish momentum. However, the RSI is neutral, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its resistance level (R1: 11.292), suggesting limited short-term upside. Historical trends indicate a likelihood of negative performance in the next week (-2.62%) and month (-6.28%).
Upcoming Q3 FY2026 financial results and conference call may provide further insights.
Bearish technical indicators and a lack of significant insider or hedge fund activity. Historical stock trend suggests negative performance in the short term.
In Q2 FY2026, revenue increased by 9.04% YoY to $79.43 million, but net income dropped to -$6.35 million (-40.86% YoY), and EPS fell to -$0.15 (-42.31% YoY). Gross margin improved to 53.05%, up 3.47% YoY.
No recent analyst rating or price target changes were provided. Wall Street sentiment appears neutral with no strong pros or cons.
